Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.34 USD | -0.03% | -0.01% | +8.16% |
05-16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
05-16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.16% | 3.44B | |
+13.89% | 130B | |
-17.54% | 7.37B | |
+46.04% | 5.87B | |
-33.09% | 4.1B | |
-19.92% | 2.47B | |
-16.33% | 1.94B | |
-24.61% | 1.72B | |
-36.56% | 1.51B | |
-17.74% | 1.05B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Needham Downgrades Axonics to Hold From Buy